Quality of Care in State Alcohol Treatment Systems

州酒精处理系统的护理质量

基本信息

  • 批准号:
    6731311
  • 负责人:
  • 金额:
    $ 15.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-02-13 至 2006-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This proposal is a revision of application number R21 AA 14195 which was originally reviewed October 10, 2002 by the National Institute on Alcohol Abuse and Alcoholism Health Services Research Review Subcommittee (AA-2). The application has been substantially revised in response to the reviewers' comments. Motivation for the project remains the growing interest in measuring (and, eventually, improving) the quality of health care provided by treatment systems. States have dominant roles in the direction and financing of treatment for people with alcohol problems. As it happens, there is marked variation from state to state in several aspects of alcohol treatment programs including expenditures for service systems and use of different treatment modalities such as outpatient versus residential care. Given this situation, it is logical to ask whether states can be ranked on the quality of care delivered by their alcohol treatment systems. Closely linked to quality of care research is the development of performance measures. A frequently discussed performance measure is the client's duration of treatment (also known as length of stay). While the evidence is not unequivocal, there is considerable data suggesting that treatment duration predicts care outcomes (including drinking, employment, and criminal activity) for people with alcohol problems. Not surprisingly, then, national guidelines for chemical dependency programs often include treatment duration as a performance measure. Moreover, in December, 2002 the Substance Abuse and Mental Health Services Administration announced that length of stay will be a developmental measure in the Performance Partnership Grant system which is replacing the block grant program, The proposed exploratory/developmental project will utilize nation-wide data from the Alcohol and Drug Services Study and similar studies, the National Association of State Alcohol and Drug Abuse Program Directors, the Treatment Episode Data Set, and the Uniform Facility Data Set to develop measures of treatment duration on a state by state and year by year basis. The length of stay indicators, in turn, will be adjusted to account for variations in client severity ("case mix differences") across states and years. Products of the study will include rankings of the states on a quality of care measure (i.e., treatment duration). The quality of care rankings will be compared with other aspects of state alcohol treatment programs such as expenditures and capacity. Preliminary work employing these methods has raised the disturbing possibility that expenditures are at best unrelated to quality of care. Consequently, the methodology and the results will be of considerable interest to alcohol treatment clients, policy makers, and payers.
描述(由申请人提供):本提案是申请号R21 AA 14195的修订版,该申请最初于2002年10月10日由国家酒精滥用和酒精中毒卫生服务研究审查小组委员会(AA-2)审查。根据审查人员的意见,对申请作了实质性修改。 该项目的动机仍然是对测量(并最终提高)治疗系统提供的医疗保健质量的日益增长的兴趣。国家在指导和资助酗酒者的治疗方面发挥主导作用。碰巧的是,各州在酒精治疗计划的几个方面存在明显差异,包括服务系统的支出和使用不同的治疗方式,如门诊与住院治疗。鉴于这种情况,合乎逻辑的是,询问各州是否可以根据其酒精治疗系统提供的护理质量进行排名。 与护理质量研究密切相关的是绩效衡量标准的制定。一个经常讨论的绩效指标是客户的治疗持续时间(也称为住院时间)。虽然证据并不明确,但有相当多的数据表明,治疗时间可以预测酒精问题患者的护理结果(包括饮酒,就业和犯罪活动)。因此,毫不奇怪,化学依赖项目的国家指南通常将治疗持续时间作为绩效衡量标准。此外,2002年12月,药物滥用和精神健康服务管理局宣布,住院时间将是绩效伙伴关系赠款制度的一项发展措施,该制度正在取代整笔赠款方案, 拟议的探索性/发展性项目将利用来自酒精和药物服务研究和类似研究、国家酒精和药物滥用项目主任协会、治疗事件数据集和统一设施数据集的全国范围的数据,以制定各州和逐年治疗持续时间的措施。 反过来,住院时间指标将进行调整,以反映各州和各年客户严重程度的变化(“病例组合差异”)。该研究的产品将包括各州在护理质量指标上的排名(即,治疗持续时间)。护理质量排名将与州酒精治疗计划的其他方面进行比较,如支出和能力。采用这些方法的初步工作提出了一种令人不安的可能性,即支出充其量与护理质量无关。 因此,方法和结果将是相当大的兴趣,酒精治疗的客户,政策制定者和付款人。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BENTSON H MCFARLAND其他文献

BENTSON H MCFARLAND的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BENTSON H MCFARLAND', 18)}}的其他基金

Outpatient versus residential treatment comparison for pregnant substance abusers
怀孕药物滥用者的门诊与住院治疗比较
  • 批准号:
    8015506
  • 财政年份:
    2010
  • 资助金额:
    $ 15.25万
  • 项目类别:
Internet Self-Help Program for Major Depressive Disorder in Spouses of Combatants
战斗人员配偶重度抑郁症互联网自助计划
  • 批准号:
    7628428
  • 财政年份:
    2007
  • 资助金额:
    $ 15.25万
  • 项目类别:
Ambulatory Patient Safety of Clients in Treatment for Substance Abuse
药物滥用治疗中客户的门诊患者安全
  • 批准号:
    7363485
  • 财政年份:
    2007
  • 资助金额:
    $ 15.25万
  • 项目类别:
Internet Self-Help Program for Major Depressive Disorder in Spouses of Combatants
战斗人员配偶重度抑郁症互联网自助计划
  • 批准号:
    7496018
  • 财政年份:
    2007
  • 资助金额:
    $ 15.25万
  • 项目类别:
Internet Self-Help Program for Major Depressive Disorder in Spouses of Combatants
战斗人员配偶重度抑郁症互联网自助计划
  • 批准号:
    7294369
  • 财政年份:
    2007
  • 资助金额:
    $ 15.25万
  • 项目类别:
Medicaid cutbacks and clients with severe mental illness
医疗补助削减和患有严重精神疾病的客户
  • 批准号:
    7197349
  • 财政年份:
    2006
  • 资助金额:
    $ 15.25万
  • 项目类别:
Medicaid cutbacks and clients with severe mental illness
医疗补助削减和患有严重精神疾病的客户
  • 批准号:
    7104645
  • 财政年份:
    2006
  • 资助金额:
    $ 15.25万
  • 项目类别:
Quality of Care in State Alcohol Treatment Systems
州酒精处理系统的护理质量
  • 批准号:
    6854584
  • 财政年份:
    2004
  • 资助金额:
    $ 15.25万
  • 项目类别:
Standardized Patients as Drug Abuse Treatment Clients
作为药物滥用治疗客户的标准化患者
  • 批准号:
    6695700
  • 财政年份:
    2003
  • 资助金额:
    $ 15.25万
  • 项目类别:
Medicaid Managed Care & Access to Alcohol Treatment
医疗补助管理式医疗
  • 批准号:
    6701820
  • 财政年份:
    2003
  • 资助金额:
    $ 15.25万
  • 项目类别:

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.25万
  • 项目类别:
    Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 15.25万
  • 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 15.25万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 15.25万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 15.25万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 15.25万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 15.25万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 15.25万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 15.25万
  • 项目类别:
Mentoring Scientists for Careers in HIV Translational Clinical Research
指导科学家从事艾滋病毒转化临床研究
  • 批准号:
    10762827
  • 财政年份:
    2023
  • 资助金额:
    $ 15.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了